Clinical outcome of methotrexate treatment for orbital inflammatory disease. The definition of an inadequate trial was treatment duration of less than 4 months. The definition of clinical benefit varied for individual patients and is detailed in the results section
| Outcome | Prevalence: fraction of total number of patients (%) |
| Inadequate trial | 4/14(29) |
| No response | 1/14 (7) |
| Clinical benefit | 9/14 (64) |
| Cessation of corticosteroid | 5/6 (83) |
| Cessation of methotrexate | 6/9‡ (67) |
↵The denominator represents the total number of patients included in the study.
↵The denominator represents the total number of patients taking systemic corticosteroid at the commencement of methotrexate therapy.
‡The denominator represents the total number of patients who responded to methotrexate therapy.